STOCK MARKET Aarti Drugs share price jumps 6% as Q4 EBITDA rises 8.9% YoY to Rs 93.4 crore May 7, 2025
Aarti Drugs stock in focus as Q2 FY25 results show 6.3% revenue decline to ₹543.09 crore; profit falls 12.1% YoY to ₹40.99 crore Oct 25, 2024
Aarti Drugs Q2 FY25 Results: Revenue declines 6.3% YoY to Rs 543 crore, Profit falls 12% YoY Oct 24, 2024